CNO Financial Group, Inc. (CNO) Analysts See $0.44 EPS

April 18, 2018 - By Adrian Erickson

CNO Financial Group, Inc. (NYSE:CNO) Logo

Analysts expect CNO Financial Group, Inc. (NYSE:CNO) to report $0.44 EPS on April, 25 after the close.They anticipate $0.10 EPS change or 29.41 % from last quarter’s $0.34 EPS. CNO’s profit would be $73.72 million giving it 12.76 P/E if the $0.44 EPS is correct. After having $0.61 EPS previously, CNO Financial Group, Inc.’s analysts see -27.87 % EPS growth. The stock increased 0.04% or $0.01 during the last trading session, reaching $22.46. About 1.34 million shares traded or 11.62% up from the average. CNO Financial Group, Inc. (NYSE:CNO) has risen 7.32% since April 19, 2017 and is uptrending. It has underperformed by 4.23% the S&P500.

CNO Financial Group, Inc. (NYSE:CNO) Ratings Coverage

Among 3 analysts covering CNO Financial (NYSE:CNO), 2 have Buy rating, 0 Sell and 1 Hold. Therefore 67% are positive. CNO Financial had 3 analyst reports since December 21, 2017 according to SRatingsIntel. The stock of CNO Financial Group, Inc. (NYSE:CNO) earned “Hold” rating by Keefe Bruyette & Woods on Thursday, December 21. On Monday, March 12 the stock rating was initiated by William Blair with “Buy”.

CNO Financial Group, Inc., through its subsidiaries, develops, markets, and administers health insurance, annuity, individual life insurance, and other insurance products for senior and middle-income markets in the United States. The company has market cap of $3.76 billion. It operates through Bankers Life, Washington National, Colonial Penn, and Long-Term Care in Run Off divisions. It has a 22.02 P/E ratio. The Bankers Life segment markets and distributes Medicare supplement insurance, interest-sensitive and traditional life insurance, fixed annuities, and long-term care insurance products; and Medicare advantage and prescription drug plan products through various distribution and marketing agreements.

CNO Financial Group, Inc. (NYSE:CNO) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.



Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: